Global Dengue Vaccine Market, By Type (Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine), Treatment (Diuretic, Anti-Allergic, Blood Thinners, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
The dengue vaccine market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a CAGR of 7.60% in the above-mentioned research forecast period. The rising prevalence of dengue incidences worldwide and emerging markets is the factor responsible for the growth of the dengue vaccine market.
Dengue virus has been spread to the people through the bite of infected Aedes species mosquitos. These mosquitos are also responsible for spread of zika, chikungunya and other viruses. Dengue is caused by dengue virus (DENV) which is a single stranded RNA positive strand virus of the family flavivirdae, genus flavivirus. DENV causes wide range of diseases in humans from self-limited dengue fever to a life threatening syndrome called dengue haemorrhagic fever (DHF). The WHO (World Health Organization) recommends that the vaccine is only be given with confirmed prior dengue virus infection.
The adoption of unhealthy lifestyle, unhygienic living conditions and increasing government support for the approval of dengue vaccine are the factors boosting the dengue vaccine market growth. However, R&D of live attenuated vaccine also aid for the growth of dengue vaccine market. For instance, in May 2019, FDA approved the dengvaxia for the prevention of dengue disease for all types of dengue fever. But, lack of patient awareness of new drugs may hamper the global dengue vaccine market.
Furthermore, the growing demand for dengue vaccine and increased government focus on dengue vaccine to invest in formulation has provided an opportunistic growth for the development of the dengue vaccine market.
This dengue vaccine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info dengue vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Dengue Vaccine Market Scope and Market Size
The dengue vaccine market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of type, the dengue vaccine market is segmented into live attenuated vaccine, chimeric live attenuated vaccine, inactivated vaccine, subunit vaccine and nucleic acid based vaccine.
- On the basis of treatment, the dengue vaccine market is segmented into diuretic, anti-allergic, blood thinners and others.
- On the basis of route of administration, the dengue vaccine market is segmented into oral, parenteral and others.
- On the basis of end-users, the dengue vaccine market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the dengue vaccine market has also been segmented into hospital pharmacy, retail pharmacy and others.
Global Dengue Vaccine Market Country Level Analysis
Global dengue vaccine market is analysed and market size information is provided by country, type, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the dengue vaccine market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa.
North America accounts the largest market share due to increasing incidences of dengue and rising health care industries. Asia-Pacific is expected to account for the largest market share over coming years for the dengue vaccine market due to increase in government expenditure for development of better healthcare infrastructures within the region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global dengue vaccine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to dengue vaccine market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the dengue vaccine market in the growth period.
Competitive Landscape and Dengue Vaccine Market Share Analysis
Global dengue vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to dengue vaccine market.
The major players covered in the dengue vaccine market are Sanofi Pasteur, Panacea Biotec, Biological E. Limited, GlaxoSmithKline plc, Merck & Co., Inc. and Takeda Pharmaceutical Company Ltd. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Dengue Vaccine Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.